Global giants enter fray for GSK’s $4bn Horlicks unit
Mumbai: Global consumer products behemoths Nestle and Unilever are among suitors who are placing bids to acquire UK pharmaceutical giant GSK’s Indian nutritional foods unit — which owns health food…
Trichy : Pharmacists to strike on Sept 28 against online sales
Trichy: The Tamil Nadu Chemists and Druggists Association (TNCDA) here on Sunday announced that pharmacies across the state would be shut on September 28, in order to showcase their opposition…
Punjab Government Planning To Cap Number Of Pharmaciest
To save the state from the drugs, the Punjab government is making efforts and now planning to put a stop on mushrooming of pharmacy shops by imposing a cap on…
Pharma sector trains students to keep talent pool flowing
Panaji: Persistent shortage of skilled workers threatens to undermine Goa’s Rs 10,000 crore pharmaceutical industry. With a significant share in pharmaceutical exports, the sector continues to struggle due to the…
Alembic Pharma gets USFDA nod for diabetes drug
New Delhi: Alembic Pharmaceuticals said Friday it has received tentative approval from the US health regulator to market Alogliptin and Metformin Hydrochloride tablets, an anti-diabetes medication, in the US market.…
Iva Healthcare posts 35% growth in terms of sales
Iva Healthcare proudly declared 35% profits growth and got new approvals for Teneligliptin 20mg and Metformin Hydrochloride 500mg {SR}. Iva gave credits of success to their new marketing strategy, competent…
ED opposes bail plea of accused in bank loan fraud case of over Rs 5K cr
New Delhi: ED opposes bail plea of accused in bank loan fraud case of over Rs 5K cr A Delhi court Thursday reserved for tomorrow its order on the bail…
Saridon, Panderm among over 6,000 medicines face ban
New Delhi: The Centre’s decision on Wednesday to ban the manufacture, sale and distribution of 328 Fixed Dose Combination (FDC) drugs has brought around 6,000 prominent medicines under the radar,…
FDA approves AstraZeneca’s drug for rare form of blood cancer
The U.S. Food and Drug Administration said on Thursday it approved AstraZeneca Plc’s treatment for hairy cell leukemia, a slow-growing type of blood cancer. The treatment, marketed as Lumoxiti, was…
Banning 328 FDCs a step towards rectifying ‘grave’ situation of pharma market: AIDAN
New Delhi: Lauding the government’s decision to ban 328 fixed-dose combination (FDC) of drugs and restricting another six, a group of NGOs Thursday said it was a step towards rectifying…
